Merrimack Pharmaceuticals Inc (MACK)
15.01
+0.01
(+0.07%)
USD |
NASDAQ |
May 06, 15:31
Merrimack Pharmaceuticals Free Cash Flow: -1.522M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.522M |
| September 30, 2023 | -1.412M |
| June 30, 2023 | -1.473M |
| March 31, 2023 | -1.744M |
| December 31, 2022 | -1.742M |
| September 30, 2022 | -1.912M |
| June 30, 2022 | -2.093M |
| March 31, 2022 | -0.135M |
| December 31, 2021 | -0.218M |
| September 30, 2021 | -1.639M |
| June 30, 2021 | -1.059M |
| March 31, 2021 | -4.057M |
| December 31, 2020 | -4.625M |
| September 30, 2020 | -5.489M |
| June 30, 2020 | -8.827M |
| March 31, 2020 | -18.72M |
| December 31, 2019 | -31.37M |
| September 30, 2019 | -47.62M |
| June 30, 2019 | -57.53M |
| March 31, 2019 | -61.90M |
| December 31, 2018 | -65.71M |
| September 30, 2018 | -71.79M |
| June 30, 2018 | -84.75M |
| March 31, 2018 | -133.64M |
| December 31, 2017 | -126.73M |
| Date | Value |
|---|---|
| September 30, 2017 | -132.42M |
| June 30, 2017 | -142.08M |
| March 31, 2017 | -128.58M |
| December 31, 2016 | -172.88M |
| September 30, 2016 | -149.30M |
| June 30, 2016 | -159.97M |
| March 31, 2016 | -135.73M |
| December 31, 2015 | -117.26M |
| September 30, 2015 | -143.18M |
| June 30, 2015 | -37.40M |
| March 31, 2015 | -44.30M |
| December 31, 2014 | -40.84M |
| September 30, 2014 | -36.06M |
| June 30, 2014 | -123.50M |
| March 31, 2014 | -114.31M |
| December 31, 2013 | -105.03M |
| September 30, 2013 | -98.01M |
| June 30, 2013 | -90.41M |
| March 31, 2013 | -86.83M |
| December 31, 2012 | -83.00M |
| September 30, 2012 | -69.55M |
| June 30, 2012 | -65.73M |
| March 31, 2012 | -65.79M |
| December 31, 2011 | -56.57M |
| September 30, 2011 | -55.34M |
Free Cash Flow Range, Past 5 Years
-57.53M
Minimum
Jun 2019
-0.135M
Maximum
Mar 2022
-10.17M
Average
-1.912M
Median
Sep 2022
Free Cash Flow Benchmarks
| NovaBay Pharmaceuticals Inc | -4.15M |
| Palatin Technologies Inc | -26.75M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -19.20M |
| Oragenics Inc | -7.291M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.295M |
| Cash from Investing (Quarterly) | 0.068M |
| Cash from Financing (Quarterly) | 0.133M |
| Free Cash Flow Per Share (Quarterly) | -0.0206 |
| Free Cash Flow Yield | -0.71% |